Page last updated: 2024-10-28

hexamethylene bisacetamide and Bewilderment

hexamethylene bisacetamide has been researched along with Bewilderment in 1 studies

N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208

Research Excerpts

ExcerptRelevanceReference
"Hexamethylene bisacetamide was administered as a 5% (w/v) solution via a nasogastric or gastrostomy tube every 4 h for 5 days, followed in 21 days by a 5-day continuous i."2.67Phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube. ( Chun, HG; Kelley, JA; Leyland-Jones, B; Lombardo, FA; Roth, JS; Ward, FT; Weiss, RB, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ward, FT1
Kelley, JA1
Roth, JS1
Lombardo, FA1
Weiss, RB1
Leyland-Jones, B1
Chun, HG1

Trials

1 trial available for hexamethylene bisacetamide and Bewilderment

ArticleYear
Phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube.
    Cancer research, 1991, Apr-01, Volume: 51, Issue:7

    Topics: Acetamides; Adult; Aged; Biological Availability; Confusion; Drug Evaluation; Female; Gastrointestin

1991